Keyword: United Kingdom

U.K. spinout building 'smell-powered' test to sniff out diseases

by Conor Hale

Monday, November 4, 2019

University of Bristol researchers are developing a device that mimics a dog's sense of smell to detect the chemical signatures of certain diseases.

Eli Lilly to shutter neuroscience R&D center next year

by Ben Adams

Tuesday, October 15, 2019

Eli Lilly is closing down its U.K.-based Erl Wood neuroscience in Surrey, leading to cuts and relocations.

Boston Pharma's combo for resistant breast cancer enters phase 1

by Arlene Weintraub

Monday, October 7, 2019

A drug that causes cancer cells to divide too rapidly and die was effective when combined with chemo in mouse models of triple-negative breast cancer.

4BIO raises VC fund to take cell and gene therapies mainstream

by Nick Paul Taylor

Sunday, September 8, 2019

The VC plans to pump $150 million into biotechs that are working to extend use of advanced therapies to major diseases such as diabetes.

Circassia

by Amirah Al Idrus

When it went public in 2014, Circassia was to be the herald of a renaissance for U.K. biotech IPOs. Instead, its pipeline of allergy treatments failed one by one, leading the Oxford-based company to ax all of them and eventually delist from the London Stock Exchange.

U.K. patient groups demand action on trial data nondisclosure

by Ben Adams

Monday, August 26, 2019

Patient groups in the U.K. are fed up with a perceived pushback from the organization set up to try to promote clinical trial transparency.

As Brexit nears, Britain's drugs, devices and pricing regulators seek the exit

by Ben Adams

Thursday, August 22, 2019

Dr. Ian Hudson is stepping down after six years in charge of the Medicines and Healthcare products Regulatory Agency next month.

NuCana's retooled chemo drug comes up short in pancreatic cancer

by Amirah Al Idrus

Wednesday, August 21, 2019

A phase 3 study of NuCana’s lead drug was halted because a monitoring committee deemed it unlikely to succeed.

U.K. plans post-Brexit easing of rules on migrant scientists

by Nick Paul Taylor

Friday, August 9, 2019

U.K. Prime Minister Boris Johnson aims to create a fast-track immigration route that facilitates the flow of talent from around the world.

U.K. commits £250M to AI lab, seeks industry partners

by Nick Paul Taylor

Thursday, August 8, 2019

The U.K. has unveiled plans to invest £250 million in a healthcare AI lab it thinks can help development of new dementia treatments.

GET THE NEWSLETTER

Subscribe to FierceBiotech to get industry news and updates delivered to your inbox.